A novel nano-proteomic methodology for biomarkers discovery in serum: early non-invasive diagnosis and subtyping of breast cancer (Q3165755): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): A novel nano-proteomic methodology for biomarkers discovery in serum: early non-invasive diagnosis and subtyping of breast cancer, translated_summary)
(‎Changed label, description and/or aliases in en: translated_label)
label / enlabel / en
 
A novel nano-proteomic methodology for biomarkers discovery in serum: early non-invasive diagnosis and subtyping of breast cancer

Revision as of 17:12, 12 October 2021

Project Q3165755 in Spain
Language Label Description Also known as
English
A novel nano-proteomic methodology for biomarkers discovery in serum: early non-invasive diagnosis and subtyping of breast cancer
Project Q3165755 in Spain

    Statements

    0 references
    97,200.0 Euro
    0 references
    121,500.0 Euro
    0 references
    80.0 percent
    0 references
    1 January 2017
    0 references
    31 March 2020
    0 references
    SERVICIO GALLEGO DE SALUD CGA
    0 references
    0 references

    43°2'46.39"N, 7°28'26.36"W
    0 references
    27028
    0 references
    A novel nano-proteomic methodology for biomarkers discovery in serum: early non-invasive diagnosis and subtyping of breast cancer (Spanish)
    0 references
    A novel nano-proteomic methodology for biomarkers discovery in serum: early non-invasive diagnosis and subtyping of breast cancer (English)
    12 October 2021
    0 references
    Lugo
    0 references

    Identifiers

    CP16_00139
    0 references